insights_auto
Why is ALGS down 4.17%?
Dive Deeperchevron_right
ALGS:NASDAQ
Aligos Therapeutics Inc
$4.60
arrow_downward
-4.17%(-0.20) 1D
$4.69
arrow_upward
+1.96% (+0.090)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALGS...
Open
$4.81
High
$4.99
Low
$4.60
Mkt. cap
28.72M
Avg. vol.
39.72K
Volume
0.00
52-wk high
$13.69
52-wk low
$3.98
EPS
-$7.31
Beta
2.36
Shares outstanding
5.44M
No. of employees
82
Open
$4.81
High
$4.99
Low
$4.60
Mkt. cap
28.72M
Avg. vol.
39.72K
Volume
0.00
52-wk high
$13.69
52-wk low
$3.98
EPS
-$7.31
Beta
2.36
Shares outstanding
5.44M
No. of employees
82
News stories
From web sources and news partners
MarketWatch
·
17 minutes ago
This signal from the corporate bond market has historically preceded big drawdowns for the S&P 500
BigGo Finance
·
43 minutes ago
NYSE Taps Broadridge to Run Onchain Voting for Its Tokenized Stock Venue
Investing.com
·
28 minutes ago
Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October
The Motley Fool
·
48 minutes ago
The Company Behind the New York Stock Exchange Is Now Building on Hyperliquid. Here's What It Means for Investors.
About Aligos Therapeutics Inc
CEO-
Employees82
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitealigos.com